在急性髓性白血病中,ZIP10作为潜在的治疗点
Benjamin Rolles1,2,3,4,5, Nicolas Chatain1,2, Richard Görg3
1Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.
British journal of haematology
|June 30, 2025
概括
急性髓性白血病 (AML) 细胞显示含量增加,推动它们的生长和生存. 向ZIP10输送器会损害的吸收,为AML患者提供一种潜在的新疗法.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 营养科学 营养科学
背景情况:
- 急性髓性白血病 (AML) 由于耐药性疾病,复发和高死亡率,在治疗中存在挑战.
- 营养因素,特别是等微量元素在AML病变发生过程中的作用尚未完全理解.
研究的目的:
- 为了研究AML中的稳态和白血病细胞对的依赖.
- 确定涉及AML的特定载体,并评估它们的治疗潜力.
主要方法:
- 利用AML细胞系和患者样本来分析水平和输送体表达.
- 进行了体外实验,以评估对髓状细胞功能的影响.
- 使用大量AML患者队列 (白血病里程和BeatAML2.0) 的数据验证了这些发现.
主要成果:
- 与对照组相比,AML爆发的细胞内含量显着更高,尽管血清低血症.
- 在恶性爆发中观察到流输送器 (包括ZIP6,ZIP9和ZIP10) 的升级.
- 对于骨髓状细胞的增殖,生存和阻断分化在体外是至关重要的.
- 向ZIP10载体导致吸收减少,并抑制恶性细胞生长.
结论:
- 甲ML细胞在生存和繁殖方面高度依赖.
- 流输送器ZIP10是AML的一个有前途的治疗标.
- 针对ZIP10可能为急性髓性白血病患者提供一种新的治疗策略.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.3K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.7K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K